0001214659-22-008950.txt : 20220718
0001214659-22-008950.hdr.sgml : 20220718
20220718163018
ACCESSION NUMBER: 0001214659-22-008950
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220715
FILED AS OF DATE: 20220718
DATE AS OF CHANGE: 20220718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Neal James R
CENTRAL INDEX KEY: 0001600865
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39801
FILM NUMBER: 221089487
MAIL ADDRESS:
STREET 1: 2910 SEVENTH STREET
CITY: BERKELEY
STATE: CA
ZIP: 94710
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: XOMA Corp
CENTRAL INDEX KEY: 0000791908
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 522154066
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 POWELL STREET
STREET 2: SUITE 310
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-204-7239
MAIL ADDRESS:
STREET 1: 2200 POWELL STREET
STREET 2: SUITE 310
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: XOMA LTD /DE/
DATE OF NAME CHANGE: 19990107
FORMER COMPANY:
FORMER CONFORMED NAME: XOMA CORP /DE/
DATE OF NAME CHANGE: 19920703
4
1
marketforms-56649.xml
PRIMARY DOCUMENT
X0306
4
2022-07-15
0000791908
XOMA Corp
XOMA
0001600865
Neal James R
C/O XOMA CORPORATION
2200 POWELL STREET, SUITE 310
EMERYVILLE
CA
94608
true
true
false
false
CEO
Common Stock
2022-07-15
4
M
false
25000
4.03
A
36822
D
Common Stock
2022-07-15
4
S
false
20883
29.5501
D
15939
D
Common Stock
2022-07-15
4
S
false
3212
31.1877
D
12727
D
Common Stock
2022-07-15
4
S
false
905
31.8610
D
11822
D
Common Stock
5560
I
By 401(k) Plan
Depositary Shares - 8.375% B Cumulative Stock
8000
I
By spouse
8.625% Series A Cumulative Perpetual Preferred Stock
8000
I
By spouse
Stock Option (Right to Buy)
4.03
2022-07-15
4
M
false
25000
0
D
2027-02-10
Common Stock
25000
218056
D
The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.25 to $30.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.53 to $31.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.53 to $32.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Shares subject to this option have fully vested as of February 10, 2020.
/s/ James R. Neal
2022-07-18